HomeCompareXVIPF vs SBUX

XVIPF vs SBUX: Dividend Comparison 2026

XVIPF yields 8.77% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBUX wins by $121.8K in total portfolio value· pulled ahead in Year 5
10 years
XVIPF
XVIPF
● Live price
8.77%
Share price
$22.81
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.7K
Annual income
$1,524.79
Full XVIPF calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — XVIPF vs SBUX

📍 SBUX pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXVIPFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XVIPF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XVIPF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XVIPF
Annual income on $10K today (after 15% tax)
$745.26/yr
After 10yr DRIP, annual income (after tax)
$1,296.07/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, SBUX beats the other by $54,668.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XVIPF + SBUX for your $10,000?

XVIPF: 50%SBUX: 50%
100% SBUX50/50100% XVIPF
Portfolio after 10yr
$96.6K
Annual income
$33,682.46/yr
Blended yield
34.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

XVIPF
Analyst Ratings
1
Buy
1
Sell
Consensus: Buy
Altman Z
16.5
Piotroski
5/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XVIPF buys
0
SBUX buys
0
No recent congressional trades found for XVIPF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXVIPFSBUX
Forward yield8.77%2.75%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$35.7K$157.5K
Annual income after 10y$1,524.79$65,840.13
Total dividends collected$12.0K$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy

Year-by-year: XVIPF vs SBUX ($10,000, DRIP)

YearXVIPF PortfolioXVIPF Income/yrSBUX PortfolioSBUX Income/yrGap
1$11,577$876.78$11,107$407.21+$470.00XVIPF
2$13,336$948.62$12,512$626.87+$824.00XVIPF
3$15,291$1,021.27$14,366$978.69+$925.00XVIPF
4$17,455$1,094.36$16,929$1,557.50+$526.00XVIPF
5← crossover$19,845$1,167.56$20,658$2,543.80$813.00SBUX
6$22,474$1,240.55$26,406$4,302.22$3.9KSBUX
7$25,361$1,313.03$35,877$7,622.00$10.5KSBUX
8$28,521$1,384.72$52,741$14,352.64$24.2KSBUX
9$31,972$1,455.38$85,676$29,243.03$53.7KSBUX
10$35,735$1,524.79$157,513$65,840.13$121.8KSBUX

XVIPF vs SBUX: Complete Analysis 2026

XVIPFStock

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

Full XVIPF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this XVIPF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XVIPF vs SCHDXVIPF vs JEPIXVIPF vs OXVIPF vs KOXVIPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.